Tryp Therapeutics |

Tryp Therapeutics

Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin.

Morgan Prestwich were retained to appoint the following:
- Chairperson
- CEO
- Non-Executive Director
- CFO
- CSO

Great Science Deserves Great Teams

Allow us to be part of your journey.
Great science truly deserves the greatest teams to deliver on the promise to patients, caregivers, and society in important areas of clinical need. Our promise is to identify the very best talent for each part of your journey towards building a fully integrated global Biopharmaceutical business.

Get in Touch